ALKBH5 and ovarian carcinoma: They discovered that both demethylase ALKBH5 and TLR4 expression were increased, confirming that ALKBH5-mediated m6A demethylation modification activates the NF-κB pathway, which promotes the invasiveness of ovarian cancer [282].